← Leaderboards
Lida P Hariri
Massachusetts General Hospital
$6,583,581
Attributed
$6,583,581
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,583,581 · 3
By mechanism
R01$5,687,661 · 2
K23$895,920 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Melissa J Suter$7,981,792
- Brett E Bouma$16,028,207
- Barry S. Shea$1,128,982
- Andrew D Luster$52,151,359
- Anand T.n. Kumar$7,313,344
Others in their field
Top investigators on “Bronchoscopy”
- Prescott G Woodruff · University Of California San Francisco$32,092,874
- Ronald G Crystal · Weill Medical College Of Cornell Univ$13,844,162
- John V Fahy · University Of California San Francisco$9,453,184
- Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr$8,758,202
- Laurence Huang · University Of California San Francisco$8,606,875
- Eugene R Bleecker · University Of California, San Diego$8,218,112
Research focus
BronchoscopyHigh RiskSensitivity And SpecificityResolutionStructure Of Parenchyma Of LungDisease ProgressionMinimally InvasiveMorbidity - Disease RateOptical Coherence TomographyOpticsLungMicroscopicLung DiseasesTissuesFibrosisMicroscopyImageBiopsyOperative Surgical ProceduresCathetersMortalityHistologyElementsEffective Therapy
Grant awards (12)
Microscopic EB-OCT imaging to predict progression in interstitial lung abnormalities$821,133
R01 · FY2025 · HL · contact PI
Microscopic EB-OCT imaging to predict progression in interstitial lung abnormalities$837,883
R01 · FY2024 · HL · contact PI
In vivo endobronchial OCT for IPF diagnosis and therapy response assessment$766,417
R01 · FY2024 · HL · contact PI
In vivo endobronchial OCT for IPF diagnosis and therapy response assessment$782,059
R01 · FY2023 · HL · contact PI
In vivo endobronchial OCT for IPF diagnosis and therapy response assessment$803,867
R01 · FY2022 · HL · contact PI
In vivo endobronchial OCT for IPF diagnosis and therapy response assessment$827,315
R01 · FY2021 · HL · contact PI
In vivo endobronchial OCT for IPF diagnosis and therapy response assessment$848,987
R01 · FY2020 · HL · contact PI
Low risk in vivo diagnosis of IPF with optical imaging$179,280
K23 · FY2020 · HL · contact PI
Low risk in vivo diagnosis of IPF with optical imaging$179,280
K23 · FY2019 · HL · contact PI
Low risk in vivo diagnosis of IPF with optical imaging$179,120
K23 · FY2018 · HL · contact PI
Low risk in vivo diagnosis of IPF with optical imaging$179,120
K23 · FY2017 · HL · contact PI
Low risk in vivo diagnosis of IPF with optical imaging$179,120
K23 · FY2016 · HL · contact PI